Patent · US Expired

Powder formulations containing tiotropium suitable for inhalation

US6881422B2 · kind B2 · utility

4Cited by
13References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 3, 2003
Grant dateApr 19, 2005
Priority date
Expiry dateApr 25, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of making a physically stable and homogenous powdered pharmaceutical composition comprising a tiotropium salt and a physiologically acceptable excipient, the method comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.